A case of primary intraocular lymphoma resistant to methotrexate therapy

Miwa Kanaumi, Hiroshi Yoshikawa, Kohei Sonoda, Keijiro Ishikawa, Tatsuro Ishibashi

研究成果: Contribution to journalArticle査読

抄録

Background: Treatment by methotrexate (MTX) for primary intraocular lymphoma (PIOL) has attracted attention in recent years. Case-report: A 51-year-old woman visited our hospital with binocular vitreous opacity that was unresponsive to therapy with corticosteroids. We diagnosed PIOL by the cytological findings and intraocular IL-10 level. Although her vitreous opacity disappeared by intravitreal MTX injection initially, in the course of repeated injections, MTX gradually became ineffective and subretinal tumor appeared, which did not respond to subsequent high-dose MTX therapy. Finally, by radiation therapy, the tumor cleared and her visual function improved. Conclusion: MTX therapy including high-dose MTX treatment may not be effective against PIOL.

本文言語英語
ページ(範囲)411-415
ページ数5
ジャーナルFolia Japonica de Ophthalmologica Clinica
2
5
出版ステータス出版済み - 5 1 2009

All Science Journal Classification (ASJC) codes

  • 眼科学

フィンガープリント

「A case of primary intraocular lymphoma resistant to methotrexate therapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル